Last updated on November 2017

A Phase 3 Clinical Trial for Patients with Moderately to Severely Active Crohn's Disease.


Brief description of study

A Phase 3 Clinical Trial for Patients with Moderately to Severely Active Crohn's Disease.

Detailed Study Description

The purpose of this study is to assess the effect of vedolizumab in the subcutaneous form.

Clinical Study Identifier: TX15247

Contact Investigators or Research Sites near you

Start Over

West Michigan Clinical Research Center

West Michigan Clinical Research Center
Wyoming, MI USA
  Connect »